Awardee OrganizationTEMPLE UNIV OF THE COMMONWEALTH
Description
Abstract Text
DESCRIPTION (provided by applicant): Progressive multifocal leukoencephalopathy
(PML) is a demyelinating disease of the central nervous system (CNS) resulting
from the lytic infection of oligodendrocytes by the human polyomavirus, JC
virus (PML was once considered a rare complication of middle-aged and elderly
patients with lymphoprolifera diseases. In recent years, however, increasingly
high incidence of PML in AIDS patients than those wit immunosuppressive
disorders led us to believe that PML may also be regarded as a AIDS-associated
disease. Lytic phase of JCV appears to be highly complex and remains elusive. A
growing body of experimental evidence suggests that the regulation of JC viral
gene expression and replication is not mediated solely by the presence absence
of a particular transcription factor in a given cell. Rather delicate
interactions among transcription or interactions between host and viral
regulatory proteins appear to be important determining factors in respect. In
support of this hypothesis, we have recently presented evidence of specific
functional interactions between a cellular factor, YB-1, and JCV T-antigen and
showed that both proteins play important roles in J expression. In addition,
our most recent published and unpublished data indicate that JCV late Agno
protein, antigen, also appears to have regulatory roles in both viral gene
expression and DNA replication through interaction with viral and cellular
proteins, notably with T-antigen and YB-1. Hence, here we propose investigate
the molecular mechanisms involved in regulation of JCV by the functional
interplay between T-antigen, Agno and YB-1. By employing molecular biology,
genetics and virological approaches, we will i) perform thorough molecular
virological studies to determine the role of Agno in regulation of JCV gene
transcription and replication by examining its physical and functional
interaction with T-antigen and YB- 1; ii) investigate the function importance
of Agno viral lytic cycle by means of both ectopic expression of Agno early in
infection mutational analysis and; iii) characterize the potential
phosphorylation sites of Agno protein and investigate the role in JCV life
cycle. The results from such comprehensive studies will provide valuable
information underlying mechanisms involved in both JCV gene regulation and
replication; and thereby the progression of JCV-induced CNS disease.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS /HIV neuropathyPolyomavirus hominis 2central nervous systemclinical researchgene deletion mutationgene expressiongenetic mappinggenetic regulationgenetic transcriptionhuman tissuenervous system disorderneural degenerationoligodendrogliaphosphorylationpoint mutationprogressive multifocal leukoencephalopathyprotein protein interactionprotein structure functiontranscription factortransfectionvirus antigenvirus proteinvirus replication
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
057123192
UEI
QD4MGHFDJKU1
Project Start Date
01-April-2002
Project End Date
31-March-2008
Budget Start Date
01-April-2006
Budget End Date
31-March-2008
Project Funding Information for 2006
Total Funding
$279,230
Direct Costs
$185,535
Indirect Costs
$93,695
Year
Funding IC
FY Total Cost by IC
2006
National Institute of Neurological Disorders and Stroke
$279,230
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS043108-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS043108-05
Patents
No Patents information available for 5R01NS043108-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS043108-05
Clinical Studies
No Clinical Studies information available for 5R01NS043108-05
News and More
Related News Releases
No news release information available for 5R01NS043108-05
History
No Historical information available for 5R01NS043108-05
Similar Projects
No Similar Projects information available for 5R01NS043108-05